Packaging and tamper-evidence in UK telehealth dispensing: what the rules actually require

A patient opens a parcel from an online pharmacy and, often without thinking about it, checks whether it looks like anyone got there first. That instinct is exactly what packaging standards are built around. For UK telehealth operators, packaging isn't a fulfilment detail decided once and forgotten — it's a GPhC and MHRA compliance surface with its own specific failure modes.

Why packaging is a compliance control, not a shipping decision

Most telehealth operators treat packaging as something decided once by whoever chose the courier, then never revisited. That's a mistake. Under GPhC standards for registered pharmacies, the superintendent pharmacist remains accountable for the safe supply of medicines right up to the point they reach the patient — and packaging sits inside that chain. A dispensed medicine that arrives with a broken seal, a missing patient information leaflet, or crushed outer packaging is, in GPhC terms, a supply that hasn't met the standard the pharmacy is required to assure.

MHRA takes the same view from the medicines-regulation side. Distance-selling rules exist partly because remote supply removes the face-to-face check a pharmacist would normally make at the counter — no chance to catch a damaged pack or question an unusual order before it leaves the building. Packaging has to do some of that reassurance work on its own.

What 'tamper-evident' actually means for a dispensed medicine

Tamper-evidence isn't one specific material or design — it's a functional requirement. A tamper-evident pack shows, through some visible and irreversible change, that it has been opened since it left the dispensary: a perforated seal, a shrink band across a cap, or an outer carton with a tear-strip that can't be reapplied cleanly. The point is that a patient can look at a package before opening it and know whether anyone got there first.

This sits alongside, but is distinct from, the anti-falsification safety features built into most prescription-only packs by the manufacturer, which a pharmacist checks inside the dispensary before the product ever reaches patient-facing packaging. That verification framework has diverged between Great Britain and Northern Ireland since the UK left the EU's scanning scheme — see our breakdown of where it currently stands for the detail on the Falsified Medicines Directive status in UK pharmacy.

The distance-selling-specific requirements

Because the medicine is supplied through a registered UK online pharmacy, distance-selling rules add a layer on top of general dispensing packaging. Our fuller rundown of what those rules cover is here — MHRA distance-selling rules: what you can and can't do online — but the part relevant to packaging is that the parcel and any accompanying paperwork need to make clear which pharmacy dispensed the medicine and how a patient reaches a pharmacist with a question, not just look cosmetically discreet.

Discretion and compliance can pull in different directions. Brands understandably want packaging that doesn't broadcast a sensitive diagnosis to a shared household or a delivery driver, and that's a legitimate patient-privacy consideration. But discreet can't mean unlabelled — the patient information leaflet, dispensing label, and any safety-critical storage instructions still have to travel with the medicine, whatever the outer box looks like.

What actually goes in the box — and what couriers do to it

A packaging spec that holds up against MHRA and GPhC expectations tends to cover the same ground:

• A tamper-evident seal or band on the primary container, applied consistently across every dispatch, not just spot-checked ones.
• The patient information leaflet and dispensing label matching the actual prescription, not a generic insert.
• Discreet outer packaging that doesn't identify contents or condition to a casual observer.
• A temperature indicator or insulated liner for any cold-chain item — covered in more depth in our cold-chain dispensing guide.
• A clear, easy route for the patient to report a broken seal or damaged parcel back to the dispensing pharmacy.

Courier handling is the variable most operators underestimate. A seal that works fine dispatched by hand can fail after a parcel spends a day moving through a sorting hub, and packaging chosen purely on cost per unit doesn't always survive transit intact. It's worth testing packaging against the actual courier and route being used, not just the supplier's spec sheet.

The failure modes GPhC and MHRA inspectors flag

None of the issues that show up in inspections or complaints are exotic. They tend to be:

• Seals applied inconsistently across a dispensing run, so some patients get a properly sealed pack and others don't.
• Missing or generic patient information leaflets when a product is repackaged from bulk stock.
• Outer packaging that reveals the medicine or condition through printed branding or a visible window.
• Batch number or expiry date obscured by a shipping label, so it can't be checked on a return.
• No documented process for what happens when a patient reports a broken seal on arrival.

A GPhC inspection is far more likely to ask to see a packaging process than to test materials in a lab. Our checklist on preparing for a GPhC inspection covers the kind of documentation that question expects.

Most packaging failures aren't about materials. They're about a seal that gets applied inconsistently on a busy Tuesday afternoon dispensing run.

Turning packaging into a standard operating procedure

The fix for most of the failure modes above is procedural, not material. A packaging SOP that specifies exactly which seal goes on which product line, who checks it before dispatch, and what the escalation path is when something's damaged in transit closes most of the gap. Our guide to writing clinical SOPs for UK telehealth covers the format that tends to survive an inspection — specific enough to audit against, short enough that staff actually follow it.

Training matters as much as the document. Packaging is often the newest or most junior role in a dispensing team, and it's easy for a written SOP to drift from what's actually happening on the floor. Periodic spot-checks — pulling a handful of dispatched-but-not-yet-shipped packages and checking them against the SOP — catch that drift before an inspector or a patient does.

How PExpo handles packaging across the dispensing layer

For brands running on PExpo's dispensing infrastructure, packaging and tamper-evidence sit inside the regulated pharmacy layer rather than being something each brand has to specify and audit independently. The superintendent pharmacist accountable for the dispensing partner sets and monitors the packaging SOP, so a brand launching a new product line inherits packaging that's already been through GPhC and MHRA scrutiny rather than starting from a blank page.

That doesn't remove the brand's interest in getting it right — patients associate a broken seal or a damaged parcel with the brand they ordered from, not the pharmacy behind it. It just means the compliance burden sits with the party best positioned to carry it, prescriber and pharmacist discretion applying throughout on how any affected medicine is handled.

Packaging is one of the few compliance touchpoints a patient actually sees, which makes it worth getting right beyond the minimum standard. If you're evaluating how a dispensing partner handles this alongside the rest of the fulfilment chain, our guide to choosing a UK dispensing partner and our same-day dispensing operations piece go deeper on the standards worth asking about, or talk to our clinics team if packaging compliance is holding up a GPhC or CQC application.

Frequently asked questions